Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Bausch Health Companies stock

Learn how to easily invest in Bausch Health Companies stock.

Bausch Health Companies Inc is a drug manufacturers-specialty & generic business based in the US. Bausch Health Companies shares (BHC) are listed on the NYSE and all prices are listed in US Dollars. Bausch Health Companies employs 19,600 staff and has a trailing 12-month revenue of around $8.2 billion.

How to buy shares in Bausch Health Companies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BHC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Bausch Health Companies stock price (NYSE: BHC)

Use our graph to track the performance of BHC stocks over time.

Bausch Health Companies shares at a glance

Information last updated 2022-09-26.
Latest market close$7.16
52-week range$4.00 - $29.31
50-day moving average $6.60
200-day moving average $16.18
Wall St. target price$17.19
PE ratio 50.2857
Dividend yield $0 (0%)
Earnings per share (TTM) $0.14

Buy Bausch Health Companies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Bausch Health Companies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bausch Health Companies price performance over time

Historical closes compared with the close of $7.16 from 2022-09-27

1 week (2022-09-21) 0.85%
1 month (2022-08-26) 38.22%
3 months (2022-06-28) -18.91%
6 months (2022-03-25) -68.62%
1 year (2021-09-28) -74.71%
2 years (2020-09-28) -53.11%
3 years (2019-09-27) 21.7
5 years (2017-09-28) 13.76

Is Bausch Health Companies stock undervalued or overvalued?

Valuing Bausch Health Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bausch Health Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bausch Health Companies's P/E ratio

Bausch Health Companies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 50x. In other words, Bausch Health Companies shares trade at around 50x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Bausch Health Companies's PEG ratio

Bausch Health Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6315. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bausch Health Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Bausch Health Companies's EBITDA

Bausch Health Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3 billion.

The EBITDA is a measure of a Bausch Health Companies's overall financial performance and is widely used to measure a its profitability.

Bausch Health Companies financials

Revenue TTM $8.2 billion
Operating margin TTM 19.48%
Gross profit TTM $6 billion
Return on assets TTM 3.43%
Return on equity TTM -328.2%
Profit margin 0.53%
Book value $1.51
Market capitalisation $2.6 billion

TTM: trailing 12 months

Bausch Health Companies's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Bausch Health Companies.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Bausch Health Companies's total ESG risk score

Total ESG risk: 41.19

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Bausch Health Companies's overall score of 41.19 (as at 12/31/2018) is pretty weak – landing it in it in the 89th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Bausch Health Companies is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Bausch Health Companies's environmental score

Environmental score: 3.36/100

Bausch Health Companies's environmental score of 3.36 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Bausch Health Companies is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Bausch Health Companies's social score

Social score: 23.99/100

Bausch Health Companies's social score of 23.99 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Bausch Health Companies is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Bausch Health Companies's governance score

Governance score: 16.84/100

Bausch Health Companies's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Bausch Health Companies is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Bausch Health Companies's controversy score

Controversy score: 4/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Bausch Health Companies scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Bausch Health Companies has a damaged public profile.

Environmental, social, and governance (ESG) summary

Bausch Health Companies Inc was last rated for ESG on: 2019-01-01.

Total ESG score 41.19
Total ESG percentile 88.8
Environmental score 3.36
Environmental score percentile 4
Social score 23.99
Social score percentile 4
Governance score 16.84
Governance score percentile 4
Level of controversy 4

Bausch Health Companies share dividends

We're not expecting Bausch Health Companies to pay a dividend over the next 12 months.

Have Bausch Health Companies's shares ever split?

Bausch Health Companies's shares were split on a 2:1 basis on 15 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bausch Health Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bausch Health Companies shares which in turn could have impacted Bausch Health Companies's share price.

Bausch Health Companies share price volatility

Over the last 12 months, Bausch Health Companies's shares have ranged in value from as little as $4 up to $29.31. A popular way to gauge a stock's volatility is its "beta".

BHC.US volatility(beta: 1.21)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bausch Health Companies's is 1.2089. This would suggest that Bausch Health Companies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Bausch Health Companies overview

Bausch Health Companies Inc. , together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally.

Frequently asked questions

What percentage of Bausch Health Companies is owned by insiders or institutions?
Currently 2.98% of Bausch Health Companies shares are held by insiders and 69.866% by institutions.
How many people work for Bausch Health Companies?
Latest data suggests 19,600 work at Bausch Health Companies.
When does the fiscal year end for Bausch Health Companies?
Bausch Health Companies's fiscal year ends in December.
Where is Bausch Health Companies based?
Bausch Health Companies's address is: 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8
What is Bausch Health Companies's ISIN number?
Bausch Health Companies's international securities identification number is: CA0717341071
What is Bausch Health Companies's CUSIP number?
Bausch Health Companies's Committee on Uniform Securities Identification Procedures number is: 071734107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site